Skip to main content

MoneyWorks4Me

Parmax Pharma informs about proceedings of AGM

21 Sep 2021 Evaluate

Parmax Pharma has informed that it enclosed summary of the proceedings as required under Regulation 30, Part-A of Schedule-III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations with respect to 27th Annual General Meeting (AGM) of the company held on Monday, 20th September, 2021 at 2:00 pm till 3.00 pm at the registered office of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..